Target intelligence / Profile preview

Urate anion exchanger 1 (URAT1) (URAT1)

Target
URAT1
Molecular classification
Transporter, Solute carrier family 22, Organic anion transporter
01

Overview

Renal urate handling is the physiological process responsible for maintaining systemic uric acid homeostasis through the coordinated action of various transporters in the kidney's proximal tubule [1, 5]. The system involves glomerular filtration followed by a complex model of reabsorption and secretion, where the most clinically significant target is Urate anion exchanger 1 (URAT1) [1, 8]. URAT1, encoded by the SLC22A12 gene, mediates the bulk of urate reabsorption from the tubular lumen back into the bloodstream [9, 16]. Other critical components include GLUT9, which handles basolateral transport, and ABCG2, which facilitates urate secretion [1, 14]. Impairment of this system is a primary cause of hyperuricemia, leading to gout and potentially contributing to chronic kidney disease [3, 4]. Therapeutic agents known as uricosurics target this system by inhibiting URAT1, thereby promoting the excretion of uric acid in the urine to lower serum concentrations [5, 15]. However, these therapies require careful management to avoid complications such as urolithiasis or acute obstructive uropathy caused by high concentrations of uric acid in the renal collecting system [11, 20].

Other names
SLC22A12Urate transporter 1Renal-specific transporterRSTOAT4LRenal urate transport system
02

Mechanism of action

Inhibition of URAT1-mediated urate reabsorption in the renal proximal tubule, leading to increased urinary excretion and decreased serum uric acid levels.

03

Biological functions

Urate transportRenal reabsorptionIon homeostasisOrganic anion exchange
04

Disease associations

GoutHyperuricemiaRenal hypouricemiaChronic kidney diseaseUrolithiasis
05

Safety considerations

Urolithiasis (kidney stones)Acute uric acid nephropathyRenal impairmentHepatotoxicityDrug-drug interactions
06

Interacting drugs

Lesinurad

8 more in the full profile.

07

Biomarkers

Serum uric acid (sUA)Fractional excretion of uric acid (FEUA)Urinary uric acid levels

Beyond the preview

Go deeper on Urate anion exchanger 1 (URAT1) (URAT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urate anion exchanger 1 (URAT1) (URAT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call